Stockscreener 앱 받기
0.646
2.17%
-0.0204
전일 마감가:
$0.6256
열려 있는:
$0.606
하루 거래량:
39,957
Relative Volume:
0.02
시가총액:
$3.16M
수익:
-
순이익/손실:
$-8.28M
주가수익비율:
-0.0141
EPS:
-45.9343
순현금흐름:
$-7.99M
1주 성능:
+0.82%
1개월 성능:
-29.22%
6개월 성능:
-18.41%
1년 성능:
-85.57%
1일 변동 폭
$0.606
$0.65
1주일 범위
$0.5698
$0.68
52주 변동 폭
$0.4772
$6.18
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Company Profile
명칭
Quoin Pharmaceuticals Ltd Adr
전화
97299741444
주소
23 HATA'AS STREET, KFAR SABA
QNRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| QNRX | 0.612 | 3.16M | 0 | -8.28M | -7.99M | -45.93 |
| VRTX | 449.94 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 745.47 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 595.78 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.36 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 108.23 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Quoin Pharmaceuticals Ltd Adr 주식(QNRX)의 최신 뉴스
Quoin Pharmaceuticals advances Netherton syndrome treatment trial - Investing.com
Quoin Pharmaceuticals granted extension to meet Nasdaq listing - Investing.com India
Quoin Pharmaceuticals granted extension to meet Nasdaq listing By Investing.com - Investing.com UK
Quoin Pharmaceuticals expands UK clinical trials for rare disease - Investing.com
Quoin Pharmaceuticals sets date for 2024 shareholder meeting - Investing.com
Balance Sheet Insights: Quoin Pharmaceuticals Ltd ADR (QNRX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Quoin Pharmaceuticals CFO buys shares worth over $23,000 - Investing.com
Healthy Upside Potential: Quoin Pharmaceuticals Ltd ADR (QNRX) - SETE News
A closer look at QNRX’s price-to-free cash flow ratio - US Post News
Quoin Pharmaceuticals COO acquires $28,737 in company shares - Investing.com
Quoin Pharmaceuticals CEO acquires shares worth over $28k - Investing.com
Quoin Pharmaceuticals (NASDAQ:QNRX) Stock Quotes, Forecast and News Summary - Benzinga
QNRX Stock Hits 52-Week Low at $0.57 Amid Market Challenges - Investing.com Australia
Quoin Pharmaceuticals to Sponsor the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 National Conference - GlobeNewswire Inc.
Quoin Pharmaceuticals partners with UCC for drug delivery tech By Investing.com - Investing.com
Quoin Pharmaceuticals director Dennis Langer sells shares worth $217 - Investing.com India
Quoin Pharmaceuticals director Dennis Langer sells shares worth $217 By Investing.com - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
GLMD Stock Quote Price and Forecast - CNN
U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.04% - Investing.com India
Major Indexes Muted Following Strong Jobs Report - Schaeffers Research
Quoin Pharmaceuticals (QNRX) Stock Price, News & Analysis - MarketBeat
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Quoin Pharmaceuticals Ltd Adr (QNRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.80%
0.42%
자본화:
|
볼륨(24시간):